Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.
Kobayashi
H
H
Department of Medicine II, Fukushima Medical University, School of Medicine, Japan.
Horner
A A
AA
Martin-Orozco
E
E
Raz
E
E
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000941:Antigens / Q000235:genetics / Q000276:immunology; D018899:CpG Islands / Q000276:immunology; D004247:DNA / Q000008:administration & dosage / Q000276:immunology; D004274:DNA, Recombinant / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D051379:Mice; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000276:immunology; D010047:Ovalbumin / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology; D001616:beta-Galactosidase / Q000235:genetics / Q000276:immunology
D000276:Adjuvants, Immunologic; D000941:Antigens; D004274:DNA, Recombinant; D009838:Oligodeoxyribonucleotides; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D010047:Ovalbumin; D004247:DNA; D001616:beta-Galactosidase